Name | 11-deoxycorticosterone pivalate |
---|---|
Synonyms |
21-pivaloyloxy-pregn-4-ene-3,20-dione
Desoxycorticosterone pivalate neodin-depositum MFCD00199992 21-Pivaloyloxy-pregn-4-en-3,20-dion Percorten pivalate deoxycorticosterone pivalate percortenm Desoxycortisone pivalate DOC PIVALATE docp cortexonem deoxycortonepivalate desoxycortone pivalate EINECS 212-366-0 |
Description | Desoxycorticosterone pivalate (DOCP) is a mineralocorticoid hormone and an analog of Desoxycorticosterone. Desoxycorticosterone pivalate is used for the management of canine hypoadrenocorticism[1][2]. |
---|---|
Related Catalog | |
In Vivo | A starting dosage of 1.5 mg/kg Desoxycorticosterone pivalate (DOCP) is effective in controlling clinical signs and serum electrolyte concentrations in the majority of dogs with PH. An additional dose reduction often is needed to maintain an injection interval of 28-30 days. Young and growing animals seem to need higher dosages[1]. |
References |
[2]. Masticatory Muscle Myositis: Pathogenesis, Diagnosis, and Treatment. |
Density | 1.111 g/cm3 |
---|---|
Boiling Point | 529.012ºC at 760 mmHg |
Melting Point | 198-204ºC |
Molecular Formula | C26H38O4 |
Molecular Weight | 414.57800 |
Exact Mass | 414.27700 |
PSA | 60.44000 |
LogP | 5.29290 |
Index of Refraction | 1.534 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 + H312 + H332 |
Precautionary Statements | P261-P280-P301 + P312 + P330 |
RIDADR | NONH for all modes of transport |